Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. - Concepedia

Concepedia

Publication | Closed Access

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

1.6K

Citations

25

References

1996

Year

I. F. Tannock, David Osoba, Martin R. Stockler, D. Scott Ernst, A. J. Neville, Malcolm J. Moore, George Armitage, Jonathan J. Wilson, Peter Venner, C Coppin,

Journal of Clinical Oncology

Abstract

Chemotherapy with mitoxantrone and prednisone provides palliation for some patients with symptomatic hormone-resistant prostate cancer.

References

	Year	Citations

Page 1